VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ELCC 2021 | Roy Castle Lung Cancer: genomics and novel risk models

John Field, MA, PhD, BDS, FRCPath, University of Liverpool, Liverpool, UK, shares an update on Roy Castle Lung Cancer research projects, including the Liverpool Lung Project which has developed and expanded the LLP risk model. Prof. Field outlines the use of the LLP risk model as well as genome-wide association studies (GWAS) looking at susceptibility genes, the discovery of molecular biomarkers, radiomics and novel risk models. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.

Disclosures

Prof. John Field, MA, PhD, BDS, FRCPath, has participated in a speaker’s bureau with AstraZeneca; has participated in advisory boards for Epigenomics, NUCLEIX Ltd., AstraZeneca and iDNA; and has received grant support from Janssen Research & Development, LLC.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter